GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Multiple sclerosis  (3)
  • Polyethylene  (1)
  • Springer  (4)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of polymers and the environment 1 (1993), S. 111-116 
    ISSN: 1572-8900
    Keywords: Polyethylene ; toxicity ; degradable plastics ; degradation rate
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Energy, Environment Protection, Nuclear Power Engineering , Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics
    Notes: Abstract Six types of starch-polyethylene degradable plastics were evaluated for the release of water-soluble toxic compounds under accelerated degradation conditions. A plastic strip (2.5×15.2 cm) was placed in a 250-ml Erlenmeyer flask with 100 ml of ASTM type I water with or without trace element solutions and shaken at 65°C and 110 rpm for 20 weeks in replicates of two. High temperature was used to accelerate the oxidative degradation of polyethylene. Plastic degradation was measured by loss of tensile strength, percentage elongation, strain energy, and weight-average molecular weight. The most rapid period of polyethylene thermal degradation was complete for most materials by day 28. Ten-milliliter aqueous samples were removed from each flask at days 1, 7, 28, 56, 84, and 140 (water volumes were maintained at 100 ml with fresh type I water), filtered through glass filters, then evaluated by using the Microtox Toxicity Analyzer (Microbics Corporation, Carlsbad, CA). No water-soluble toxic compounds were detected during the period of rapid film degradation. Toxicity was observed at day 28 for one film and at day 84 for all films, which could possibly correlate with the release of small oxidative compounds such as formaldehyde and acetaldehyde. Because of the sensitivity of this assay, positive results must be confirmed by otherin vitro studies.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 75 (1997), S. 89-94 
    ISSN: 1432-1440
    Keywords: Key words Interferon ; Multiple sclerosis ; Chronic progressive ; Relapsing-remitting
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract  Human interferon (IFN) β is the first therapeutic agent to convincingly reduce the multiple sclerosis relapse rate and retard disability. To achieve this significant treatment advance over 15 years of preliminary work was necessary, encompassing over 15 controlled trials which employed each of the three human interferons. Important insights into the pathogenesis of multiple sclerosis (MS) were gained, especially from the findings of the single IFN-γ trial. This short history describes the unfolding of our current understanding of the place for IFNs in the management of MS. The contribution of the patients who have participated is recognized and their courage acknowledged. The final role for IFN treatment of MS is unclear, but future studies will be required to define the best IFN, optimal dose, and route of administration and patient selection for long-term management of MS.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of neurology 243 (1996), S. S3 
    ISSN: 1432-1459
    Keywords: Copolymer 1 ; Multiple sclerosis ; Experimental allergic encephalomyelitis ; Interferon beta
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Copolymer 1 (Copaxone) is a mixture of synthetic peptides composed of four amino acids. It has been shown to alter positively the natural history of multiple sclerosis by both reducing the relapse rate and affecting disability. A recently completed, large-scale, phase III, multicenter, double-blind study confirmed the therapeutic benefit shown in previous pilot studies. Side effects were mild and the daily subcutaneous treatment was well tolerated. Laboratory studies have shown that copolymer 1 prevents or modifies experimental allergic encephalomyelitis in several mammalian species. It induces immunologic suppressor cells, which are deficient in multiple sclerosis, and competitively inhibits the effect of central nervous system myelin antigens, thought to be important in the pathogenesis of multiple sclerosis. Copolymer 1 joins interferon beta in ushering in a new era of well-tolerated treatments for multiple sclerosis.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of clinical immunology 5 (1985), S. 386-389 
    ISSN: 1573-2592
    Keywords: Multiple sclerosis ; gamma interferon ; lymphokines ; autoimmunity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The production of gamma interferon (IFN) by mononuclear cells (MNC) from patients with exacerbating/remitting multiple sclerosis (MS) and controls was evaluated. After 3 days of culture with concanavalin A, the amount of gamma IFN in supernatant fluids was determined by radioimmunoassay. MNC from MS patients produced significantly (P〈0.001) more gamma IFN than MNC from either normal controls or patients with other neurologic diseases. Levels of gamma IFN in the serum and CSF were also measured. Despite the relative absence of gamma IFN in serum (4 positive of 30), all CSF samples tested had low, but detectable, levels of gamma IFN (0.3 to 1.4 U/ml). These studies suggest that some of the autoimmune features and immunologic abnormalities in MS may be related to elevated gamma IFN production.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...